Receptor activator of NF-kappaB and Podocytes: Towards a function of a novel receptor-ligand pair in the survival response of podocyte injury

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Liu, Shuangxin ^a,b   Shi, Wei ^a   Xiao, Houqin ^a   Liang, Xinling ^a   Deng, Chunyu ^a   Ye, Zhiming ^a   Mei, Ping ^a   Wang, Suxia ^c   Liu, Xiaoying ^a   Shan, Zhixin ^a   Liang, Yongzheng ^a   Zhang, Bin ^a   Wang, Wenjian ^a   Liu, Yanhui ^a   Xu, Lixia ^a   Xia, Yunfeng ^a   Ma, Jianchao ^a   Li, Zhilian ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DAMAGE; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENE; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; LIGAND BINDING; MALE; MOUSE; NEPHROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PODOCYTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B GENE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND GENE; SCID MOUSE; T LYMPHOCYTE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL LINE, TRANSFORMED; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY GLOMERULUS; MALE; MICE; MICE, SCID; NEPHROSIS; PODOCYTES; PUROMYCIN; RANK LIGAND; RATS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

RATTUS;

EID: 84864348427     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041331     Document Type: Article

References (48)

1. Abrahamson DR, (1987) Structure and development of the glomerular capillary wall and basement membrane. Am J Physiol 253: F783-794.
2. Wiggins RC, (2007) The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71: 1205-1214.
3. Asanuma K, Mundel P, (2003) The role of podocytes in glomerular pathobiology. Clin Exp Nephrol 7: 255-259.
4. Barisoni L, Mundel P, (2003) Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol 23: 353-360.
5. Leeuwis JW, Nguyen TQ, Dendooven A, Kok RJ, Goldschmeding R, (2010) Targeting podocyte-associated diseases. Adv Drug Deliv Rev 62: 1325-1336.
6. D'Agati VD, (2008) Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts). Kidney Int 73: 399-406.
7. Cybulsky AV, (2011) Membranous nephropathy. Contrib Nephrol 169: 107-125.
8. Xu L, Yang HC, Hao CM, Lin ST, Gu Y, Ma J, (2010) Podocyte number predicts progression of proteinuria in IgA nephropathy. Mod Pathol 23: 1241-1250.
9. Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, et al. (2004) Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113: 1390-1397.
10. Bollain-Y-Goytia JJ, González-Castañeda M, Torres-Del-Muro F, Daza-Benitez L, Zapata-Benavides P, et al. (2011) Indian J Nephrol 21: 166-171.
11. Mundel P, Shankland SJ, (2002) Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005-3015.
12. Durvasula RV, Shankland SJ, (2006) Podocyte injury and targeting therapy: an update. Curr Opin Nephrol Hypertens 5: 1-7.
13. Vega-Warner V, Ransom RF, Vincent AM, Brosius FC, Smoyer WE, (2004) Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside. Kidney Int 66: 1881-1889.
14. Lee SC, Han SH, Li JJ, Lee SH, Jung DS, et al. (2009) Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. Kidney Int 76: 838-848.
15. Zou J, Yaoita E, Watanabe Y, Yoshida Y, Nameta M, et al. (2006) Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch 448: 485-492.
16. Tsui CC, Shankland SJ, Pierchala BA, (2006) Glial cell line-derived neurotrophic factor and its receptor ret is a novel ligand-receptor complex critical for survival response during podocyte injury. J Am Soc Nephro 17: 1543-1552.
17. Saito Y, Okamura M, Nakajima S, Hayakawa K, Huang T, et al. (2010) Suppression of nephrin expression by TNF-alpha via interfering with the cAMP-retinoic acid receptor pathway. Am J Physiol Renal Physiol 298: F1436-1444.
18. Sanchez-Niño MD, Benito-Martin A, Gonçalves S, Sanz AB, Ucero AC, et al. (2010) TNF superfamily: a growing saga of kidney injury modulators. Mediators Inflamm pii.
19. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, et al. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175-179.
20. Ueland T, Yndestad A, Øie E, Florholmen G, Halvorsen B, et al. (2005) Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure. Circulation 111: 2461-2468.
21. Wiethe C, Dittmar K, Doan T, Lindenmaier W, Tindle R, et al. (2003) Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen. J Immunol 171: 4121-4130.
22. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, et al. (1999) RANK is essential for osteoclast and lymph node development. Genes Dev 13: 2412-2424.
23. Bharti AC, Aggarwal BB, (2004) Ranking the role of RANK ligand in apoptosis. Apoptosis 9: 677-690.
24. Kim HH, Shin HS, Kwak HJ, Ahn KY, Kim JH, et al. (2003) RANKL regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. FASEB J 17: 2163-2165.
25. Hess E, Duheron V, Decossas M, Lézot F, Berdal A, et al. (2012) RANKL induces organized lymph node growth by stromal cell proliferation. J Immunol 188: 1245-1254.
26. Duheron V, Hess E, Duval M, Decossas M, Castaneda B, et al. (2011) Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. Proc Natl Acad Sci USA 108: 5342-5347.
27. Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, et al. (1999) Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 25: 525-534.
28. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, et al. (2009) Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol 296: F213-229.
29. Mundel P, Heid HW, Mundel TM, Krüger M, Reiser J, et al. (1997) Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol 139: 193-204.
30. Bao L, Haas M, Pippin J, Wang Y, Miwa T, et al. (2009) Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. J Clin Invest 119: 1264-1274.
31. Wei C, Möller CC, Altintas MM, Li J, Schwarz K, et al. (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14: 55-63.
32. Chen S, Lee JS, Iglesias-de la Cruz MC, Wang A, Izquierdo-Lahuerta A, et al. (2005) Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy. Nephrol Dial Transplant 20: 1320-1328.
33. Wall NR, Shi Y, (2003) Small RNA: can RNA interference be exploited for therapy? Lancet 362: 1401-1403.
34. George S, Brenner A, Sarantopoulos J, Bukowski RM, (2010) RANK ligand: effects of inhibition. Curr Oncol Rep 12: 80-86.
35. Fata JE, Kong YY, Li J, Sasaki T, Irie-Sasaki J, et al. (2000) The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103: 41-50.
36. Beleut M, Rajaram RD, Caikovski M, Ayyanan A, Germano D, et al. (2010) Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc Natl Acad Sci US 107: 2989-2994.
37. Akiyama T, Shimo Y, Yanai H, Qin J, Ohshima D, et al. (2008) The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity 29: 423-437.
38. Knoop KA, Kumar N, Butler BR, Sakthivel SK, Taylor RT, et al. (2009) RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium. J Immunol 183: 5738-5747.
39. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, et al. (2007) Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin. Nature 446: 690-694.
40. Gonzalez-Suarez E, Jacob AP, Jones J, Miller R, Roudier-Meyer MP, et al. (2010) RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 468: 103-107.
41. Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, et al. (2010) Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468: 98-102.
42. Soifer NE, Van Why SK, Ganz MB, Kashgarian M, Siegel NJ, et al. (1993) Expression of parathyroid hormone-related protein in the rat glomerulus and tubule during recovery from renal ischemia. J Clin Invest 92: 2850-2857.
43. Sanchez-Niño MD, Sanz AB, Ihalmo P, Lassila M, Holthofer H, et al. (2009) The MIF receptor CD74 in diabetic podocyte injury. J Am Soc Nephrol 20: 353-362.
44. Cheng H, Fan X, Guan Y, Moeckel GW, Zent R, et al. (2009) Distinct roles for basal and induced COX-2 in podocyte injury. J Am Soc Nephrol 20: 1953-1962.
45. Cheng H, Fan X, Moeckel GW, Harris RC, (2011) Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro) renin receptor expression. J Am Soc Nephrol 22: 1240-1251.
46. Xiao HQ, Shi W, Liu SX, Zhang B, Xu LX, et al. (2009) Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats. Clin Exp Pharmacol Physiol 36: 682-689.
47. Gagliardini E, Conti S, Benigni A, Remuzzi G, Remuzzi A, (2010) Imaging of the porous ultrastructure of the glomerular epithelial filtration slit. J Am Soc Nephrol 21: 2081-2089.
48. Xiao H, Shi W, Liu S, Wang W, Zhang B, et al. (2009) 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway. Am J Nephrol 30: 34-43.